PL3493835T3 - Sposób indukowania ex vivo limfocytów supresorowych roztworem białek z pasożyta z grupy helmintów - Google Patents

Sposób indukowania ex vivo limfocytów supresorowych roztworem białek z pasożyta z grupy helmintów

Info

Publication number
PL3493835T3
PL3493835T3 PL17772758.3T PL17772758T PL3493835T3 PL 3493835 T3 PL3493835 T3 PL 3493835T3 PL 17772758 T PL17772758 T PL 17772758T PL 3493835 T3 PL3493835 T3 PL 3493835T3
Authority
PL
Poland
Prior art keywords
helmint
supressor
parasite
lymphocytes
group
Prior art date
Application number
PL17772758.3T
Other languages
English (en)
Inventor
Katarzyna Donskow-Łysoniewska
Original Assignee
Uniwersytet Warszawski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Warszawski filed Critical Uniwersytet Warszawski
Publication of PL3493835T3 publication Critical patent/PL3493835T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0008—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/10—Cellular immunotherapy characterised by the cell type used
    • A61K40/11—T-cells, e.g. tumour infiltrating lymphocytes [TIL] or regulatory T [Treg] cells; Lymphokine-activated killer [LAK] cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/20—Cellular immunotherapy characterised by the effect or the function of the cells
    • A61K40/22—Immunosuppressive or immunotolerising
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/405—Invertebrates antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • A61K40/40—Cellular immunotherapy characterised by antigens that are targeted or presented by cells of the immune system
    • A61K40/41—Vertebrate antigens
    • A61K40/416—Antigens related to auto-immune diseases; Preparations to induce self-tolerance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/577—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 tolerising response
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K40/00
    • A61K2239/38—Indexing codes associated with cellular immunotherapy of group A61K40/00 characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PL17772758.3T 2016-08-04 2017-08-04 Sposób indukowania ex vivo limfocytów supresorowych roztworem białek z pasożyta z grupy helmintów PL3493835T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL418202A PL418202A1 (pl) 2016-08-04 2016-08-04 Sposób indukowania ex vivo limfocytów o fenotypie CD8+CD25+FOXP3-, limfocyty indukowane tym sposobem do zastosowanie w sposobach zapobiegania i leczenia chorób oraz roztwór białek z pasożyta z grupy helmintów do zastosowania w sposobie indukowania limfocytów o fenotypie CD8+CD25+FOXP3-u potrzebującego tego osobnika
PCT/IB2017/054790 WO2018025236A1 (en) 2016-08-04 2017-08-04 Method for ex vivo induction of suppressor lymphocytes using a solution of proteins from helminth parasites, lymphocytes produced by this method and uses thereof

Publications (1)

Publication Number Publication Date
PL3493835T3 true PL3493835T3 (pl) 2024-02-12

Family

ID=59969189

Family Applications (2)

Application Number Title Priority Date Filing Date
PL418202A PL418202A1 (pl) 2016-08-04 2016-08-04 Sposób indukowania ex vivo limfocytów o fenotypie CD8+CD25+FOXP3-, limfocyty indukowane tym sposobem do zastosowanie w sposobach zapobiegania i leczenia chorób oraz roztwór białek z pasożyta z grupy helmintów do zastosowania w sposobie indukowania limfocytów o fenotypie CD8+CD25+FOXP3-u potrzebującego tego osobnika
PL17772758.3T PL3493835T3 (pl) 2016-08-04 2017-08-04 Sposób indukowania ex vivo limfocytów supresorowych roztworem białek z pasożyta z grupy helmintów

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL418202A PL418202A1 (pl) 2016-08-04 2016-08-04 Sposób indukowania ex vivo limfocytów o fenotypie CD8+CD25+FOXP3-, limfocyty indukowane tym sposobem do zastosowanie w sposobach zapobiegania i leczenia chorób oraz roztwór białek z pasożyta z grupy helmintów do zastosowania w sposobie indukowania limfocytów o fenotypie CD8+CD25+FOXP3-u potrzebującego tego osobnika

Country Status (4)

Country Link
EP (1) EP3493835B1 (pl)
FI (1) FI3493835T3 (pl)
PL (2) PL418202A1 (pl)
WO (1) WO2018025236A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3091547A1 (en) * 2018-04-05 2019-10-10 Helmholtz Zentrum Muenchen - Deutsches Forschungszentrum Fuer Gesundheit Und Umwelt (Gmbh) Larval preparation of heligmosomoides polygyrus bakeri as well as methods of making it and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050118655A1 (en) * 2003-11-17 2005-06-02 University Of Iowa Research Foundation Use of parasitic biological agents for diseases prevention and control
WO2013039872A1 (en) * 2011-09-12 2013-03-21 Tufts Medical Center Compositions and methods for treating inflammatory bowel diseases
CA2877286C (en) * 2012-06-18 2023-05-16 Yale University Compositions and methods for diminishing an immune response

Also Published As

Publication number Publication date
WO2018025236A1 (en) 2018-02-08
EP3493835B1 (en) 2023-08-16
EP3493835A1 (en) 2019-06-12
PL418202A1 (pl) 2018-02-12
FI3493835T3 (fi) 2023-09-20

Similar Documents

Publication Publication Date Title
LT3367897T (lt) Elektrokardiogramos automatinio apibrėžimo arba kategorizavimo būdas
DK3625259T3 (da) Anti-sirpalpha-antistoffer
IL254516B (en) Proteins specific for cd137
DK3964529T3 (da) Ikke-blokerende pd1-specifikke antistoffer
DK3344654T3 (da) Anti-lag-3-antistoffer
EP3319984C0 (en) TAU LINKING ANTIBODIES
HUE047175T2 (hu) Eljárások nukleinsavak tanulmányozására
MA53297A (fr) Anticorps anti-icos
DK3350218T5 (da) Polyomavirus-neutraliserende antistoffer
HUE060878T2 (hu) Anti-transztiretin antitestek
DK3250593T3 (da) Anti-transthyretin-antistoffer
EP3319983C0 (en) TAU LINKING ANTIBODIES
DK3606961T3 (da) Garp-tgf-beta-antistoffer
IT201600128513A1 (it) Gruppo pedivella
HUE042606T2 (hu) Eljárás apolipoprotein kimutatására
SMT202100042T1 (it) Ligandi potenzializzanti della bioattivita' delle gonadotropine
DK3463001T3 (da) Kogegrej
EP3634634A4 (en) Trans-interfacial magnetic separation
EP3356239A4 (en) DISPOSAL OF DEFECTIVE LABELS
DK3484921T3 (da) Anti-IL-22R antistoffer
DK3452515T3 (da) Her-2-bindende antistoffer
IL251157B (en) Impairment detection with biological considerations
EP3394538A4 (en) OXYGEN DEPOSITION OF HYDROCARBONS
EP3375464A4 (en) BREAST PUMP
EP3335725A4 (en) IMMUNITÄTSINDUZIERER